-transparent.png){kind=logo}
It has been found that gastrointestinal side-effects of indomethacin could be abolished when administered in combination indomethacin:sodium salicylate (ratio 1:10). In this paper comparative pharmacological data of this combination and its basal compounds are presented. Acute toxicity of the combined preparation was 72 times less in rats than that of indomethacin alone. All therapeutic indexes were markedly increased in the combination of indomethacin-sodium salicylate compared with the separate drug treatments.
Related Publications
E Ezer, and
E Pálosi, and
G Hajós, and
B Rosdy, and
L Szporny
January 1984,
Acta physiologica Hungarica,
E Ezer, and
E Pálosi, and
G Hajós, and
B Rosdy, and
L Szporny
November 1979,
International journal of clinical pharmacology and biopharmacy,
E Ezer, and
E Pálosi, and
G Hajós, and
B Rosdy, and
L Szporny
January 1984,
Acta physiologica Hungarica,
E Ezer, and
E Pálosi, and
G Hajós, and
B Rosdy, and
L Szporny
January 1981,
Farmakologiia i toksikologiia,
E Ezer, and
E Pálosi, and
G Hajós, and
B Rosdy, and
L Szporny
October 1947,
The Quarterly journal of medicine,
E Ezer, and
E Pálosi, and
G Hajós, and
B Rosdy, and
L Szporny
January 1952,
Trudy. Vsesoiuznoe fiziologicheskoe obshchestvo imeni I. P. Pavlova. Orenburgskoe otdelenie,
E Ezer, and
E Pálosi, and
G Hajós, and
B Rosdy, and
L Szporny
January 1978,
Acta physiologica Academiae Scientiarum Hungaricae,
E Ezer, and
E Pálosi, and
G Hajós, and
B Rosdy, and
L Szporny
January 1990,
Agents and actions,
E Ezer, and
E Pálosi, and
G Hajós, and
B Rosdy, and
L Szporny
May 1977,
Archives of dermatology,
E Ezer, and
E Pálosi, and
G Hajós, and
B Rosdy, and
L Szporny
January 1961,
Therapie,
